Legal Representation
Attorney
Mary Catherine Merz
USPTO Deadlines
Next Deadline
2145 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20251202)
Due Date
December 02, 2031
Grace Period Ends
June 02, 2032
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
16 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 8, 2025 | PPAD | O | POST PUBLICATION AMENDMENT REVIEWED – NO ACTION TAKEN | Loading... |
| Dec 4, 2025 | APET | A | ASSIGNED TO PETITION STAFF | Loading... |
| Dec 2, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Dec 2, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Nov 3, 2025 | CHPB | I | POST PUBLICATION AMENDMENT - ENTERED | Loading... |
| Nov 3, 2025 | APET | A | ASSIGNED TO PETITION STAFF | Loading... |
| Oct 16, 2025 | EPPA | I | TEAS POST PUBLICATION AMENDMENT RECEIVED | Loading... |
| Oct 14, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Oct 14, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Oct 8, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Sep 25, 2025 | EPPA | I | TEAS POST PUBLICATION AMENDMENT RECEIVED | Loading... |
| Sep 12, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Aug 21, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 27, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Mar 27, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Mar 27, 2025 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Dietary supplements in the form of capsules for use in connection with endometriosis and cyclical pelvic pain
First Use Anywhere:
Mar 19, 2025
First Use in Commerce:
Mar 19, 2025
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"ENDO"